Current and Emerging Treatment Options in Diabetes Care

Christoffer Clemmensen, Timo D Müller, Brian Finan, Matthias H Tschöp, Richard DiMarchi

Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

19 Citationer (Scopus)

Abstract

Diabetes constitutes an increasing threat to human health, particularly in newly industrialized and densely populated countries. Type 1 and type 2 diabetes arise from different etiologies but lead to similar metabolic derangements constituted by an absolute or relative lack of insulin that results in elevated plasma glucose. In the last three decades, a set of new medicines built upon a deeper understanding of physiology and diabetic pathology have emerged to enhance the clinical management of the disease and related disorders. Recent insights into insulin-dependent and insulin-independent molecular events have accelerated the generation of a series of novel medicinal agents, which hold the promise for further advances in the management of diabetes. In this chapter, we provide a historical context for what has been accomplished to provide perspective for future research and novel emerging treatment options.

OriginalsprogEngelsk
TitelMetabolic Control
Antal sider23
Vol/bind233
ForlagSpringer
Publikationsdato2016
Sider437-459
ISBN (Trykt)978-3-319-29804-7
ISBN (Elektronisk)978-3-319-29806-1
DOI
StatusUdgivet - 2016
Udgivet eksterntJa
NavnHandbook of Experimental Pharmacology
Nummer233
ISSN0171-2004

Citationsformater